Drug Design Development and Therapy · 2019 · 32 citations · 18 references
Life SciencesNutritional SciencesPharmacologyChemotherapyGastrointestinal PharmacotherapyMicrobiome ResearchGastrointestinal PharmacologyGastrointestinal ToxicityGut HealthGut MicrobiomeGut MicrobiotaBody Weight RegulationGut Microbiome AlterationsGut Microbiome DiversityGut Microbiota EffectsIntestinal Microbiota EffectsMatched Control GroupNutritional ImpactRelative Abundance Analysis
Purpose: [6]-gingerol is one of the main components of ginger with many biological activities. In this study, the effects of ondansetron and [6]-gingerol on pica and gut microbiota in rats injected with cisplatin were evaluated. Materials and methods: Rat model of cisplatin-induced pica was established, and the effects of ondansetron and [6]-gingerol on the gut microbiota were further studied by 16S rDNA gene analysis. Results: The results showed that the total intake of kaolin of the rats injected with cisplatin was significantly increased, and treatment of ondansetron and [6]-gingerol in advance could significantly ameliorate the pica induced by cisplatin. The body weight of the rats injected with cisplatin was decreased compared with the control group. The 16S rDNA gene analysis has shown that ondansetron, [6]-gingerol and cisplatin could increase the relative abundance of Bacteroidetes and decrease Firmicutes on phylum level. Conclusion: [6]-gingerol was as effective as ondansetron in the treatment of pica induced by cisplatin in rats, and it seemed that [6]-gingerol had the potential to ameliorate the alteration of gut microbiome, but it needs further study. Keywords: [6]-gingerol, ondansetron, kaolin, pica, gut microbiota, cisplatin
18
An obesity-associated gut microbiome with increased capacity for energy harvest
Peter J. Turnbaugh, Ruth E. Ley, Michael A. Mahowald et al. · Nature · 2006 · 12.4K citations
Cheng-Hsi Wu, Jiunn‐Liang Ko, Jiuan‐Miaw Liao et al. · Therapeutic Advances in Medical Oncology · 2019 · 105 citations · Full text